Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowena A Bull

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Journal of Hepatology|April 11, 2024
B-cell characteristics define HCV reinfection outcomeAlexander P Underwood, Money Gupta, Bing-Ru Wu, et al.
Immunology and Cell Biology|November 10, 2022
High activation levels maintained in receptor-binding domain-specific memory B cells in people with severe coronavirus disease 2019Money Gupta, Harikrishnan Balachandran, Raymond H Y Louie, et al.
The Journal of Infectious Diseases|August 31, 2016
Historical Trends in the Hepatitis C Virus Epidemics in North America and AustraliaChaturaka Rodrigo, Auda A Eltahla, Rowena A Bull, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 InfectionAnurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, et al.
Hepatology Communications|February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic reviewSofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 10, 2017
Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infectionChaturaka Rodrigo, Melanie R Walker, Preston Leung, et al.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Nature Communications|December 7, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseasePaul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, et al.
Immunity|January 16, 2025
A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune diseaseClara Young, Mandeep Singh, Katherine J L Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodiesOhan Mazigi, David B Langley, Jake Y Henry, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Journal of Hepatology|April 11, 2024
B-cell characteristics define HCV reinfection outcomeAlexander P Underwood, Money Gupta, Bing-Ru Wu, et al.
Immunology and Cell Biology|November 10, 2022
High activation levels maintained in receptor-binding domain-specific memory B cells in people with severe coronavirus disease 2019Money Gupta, Harikrishnan Balachandran, Raymond H Y Louie, et al.
The Journal of Infectious Diseases|August 31, 2016
Historical Trends in the Hepatitis C Virus Epidemics in North America and AustraliaChaturaka Rodrigo, Auda A Eltahla, Rowena A Bull, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 InfectionAnurag Adhikari, Arunasingam Abayasingam, Chaturaka Rodrigo, et al.
Hepatology Communications|February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic reviewSofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 10, 2017
Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infectionChaturaka Rodrigo, Melanie R Walker, Preston Leung, et al.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Nature Communications|December 7, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseasePaul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, et al.
Immunity|January 16, 2025
A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune diseaseClara Young, Mandeep Singh, Katherine J L Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodiesOhan Mazigi, David B Langley, Jake Y Henry, et al.
Pageof 12